135036-38-3Relevant articles and documents
Synthesis, cardiac electrophysiology, and β-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents
Phillips,Morgan Jr.,Lumma Jr.,Gomez,Lind,Lis,Argentieri,Sullivan
, p. 743 - 750 (2007/10/02)
A series of novel arylpiperazines have been prepared in an attempt to incorporate both class II (β-receptor blocking) and class III antiarrhythmic properties in a single molecule. The key step in the preparation of the new compounds involves a regioselect